Cardiopulmonary bypass equipment are devices that are used to oxygenate and circulate blood outside the body during cardiac surgery. Global cardiopulmonary bypass equipment market has been witnessing growth over the past few years due to rising cases of cardiovascular diseases and rising demand for minimally invasive surgical procedures. Cardiopulmonary bypass allows temporary takeover of heart and lung functions during procedures such as open-heart surgery. It enables surgeons to work on a still heart while the patient's blood is pumped, oxygenated, and returned to circulation. Advancements in cardiopulmonary

y bypass systems with improved technology for safety, efficiency, and precision have been facilitating complex surgeries and driving the market growth.

Market Dynamics:

Global cardiopulmonary bypass equipment market growth is driven by factors like rising prevalence of cardiovascular diseases globally due to unhealthy lifestyle habits and growing geriatric population. According to the data published by WHO, cardiovascular diseases or CVDs are a major cause of mortality worldwide, with an estimated 17.9 million people die due to CVDs each year. Increasing demand for minimally invasive procedures coupled with product innovations to reduce surgical risk, trauma, and recovery time can boost adoption of cardiopulmonary bypass systems. However, high costs associated with bypass equipment and surgeries can hamper the market growth. Meanwhile, emerging economies along with growing medical tourism and improving healthcare infrastructure and services can offer market growth opportunities.

Key Features of the Study:

• This report provides in-depth analysis of the global cardiopulmonary bypass equipment market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global cardiopulmonary bypass equipment market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Medtronic, Sorin Group, Terumo Corporation, MAQUET, Braile Biomedica, and Tianjin Medical
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global cardiopulmonary bypass equipment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cardiopulmonary bypass equipment market

Detailed Segmentation-

• By Product Type
  
  • Single Roller Pump
  • Double Roller Pump
• By End User
  
  • Hospitals
  • Ambulatory Surgical Centres 
  • Others
    
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Medtronic
  • LivaNova
  • Terumo Cardiovascular Systems Corporation
  • Maquet Holding BV & Co. KG
  • Braun Melsungen AG
  • Medica s.p.a.
  • Eurosets
  • Fresenius Medical Care AG & Co. KGaA
  • Lepu Medical Technology
  • Elite Life Care
  • OriGen Biomedical
  • Tianjin Medical
  • Soma Technology, Inc.
  • Braile Biomédica
  • CardioGenesis Corporation (part of Philips)
  • Century Medical, Inc.
  • Nonin Medical, Inc.
  • Xijian Medical